Browse by author
Lookup NU author(s): Professor Chris Day
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Investigators searching for genetic factors involved in NASH susceptibility using available technology face several potential pitfalls. These can be overcome by appropriate and careful study design, however, and recent advances in understanding of basic disease mechanisms have suggested a range of genes worthy of subjecting to SNP screening strategies and case-control allele association studies. In the future, the selection of candidate genes seems likely to be guided by mRNA and protein expression profiling of serum and liver tissue from patients with different stages of disease, and possibly, by phenotype-driven mouse mutagenesis approaches. Eventually the availability of a comprehensive SNP-based haplotype map of the human genome along with economically viable rapid throughput genotyping technology will enable genome-wide, haplotype-based association studies in NASH. Together, these modern approaches are likely to lead to the identification of many, as yet unknown, or, at best, unsuspected susceptibility genes that will enhance understanding of disease pathogenesis, and accordingly, the ability to design effective therapies.
Author(s): Day CP
Publication type: Review
Publication status: Published
Journal: Clinics in Liver Disease
Year: 2004
Volume: 8
Issue: 3
Pages: 673-691
ISSN (print): 1089-3261
ISSN (electronic): 1557-8224
URL: http://dx.doi.org/10.1016/j.cld.2004.04.001
DOI: 10.1016/j.cld.2004.04.001